Boston Biopharma is a science-driven, patient-focused company seeking to leverage its strengths across the continuum from drug discovery to commercialization in its goal of providing better treatments for people with serious diseases.

  • Started in 2003

  • Operations in the US, Europe (Malta), Turkey, Iraq, Algeria, and Ukraine.

  • Successfully launched 12 specialty products and built a GMP facility from the ground up, with two additional facilities under development

The core and success of our continuous drive for excellence is expressed in the values of our global team. Their commitment and sense of responsibility are derived from the awareness that every product that we provide will affect another person’s life. We feel we have a personal connection with every patient whose life is affected by our products.

Boston Biopharma provides solutions that enable positive outcomes and lead to positive patient stories. Our promise is to empower physicians, nurses, and other healthcare professionals with the tools they need to provide better healthcare and transform lives.

Who We Are 


Quality. Collaboration. Excellence.

At Boston Biopharma, business development is integral to our mission of growing a leading and independent biopharmaceutical company. Through our innovative approach, we aim to identify partners with whom we can jointly advance therapeutics into our target markets, either in direct collaboration, or through licensing of our products or our intellectual property.

Another component of Boston Biopharma’s growth strategy is to build upon this success and actively seek new product candidates to expand our pipeline. We seek products that fulfill poorly or unmet medical needs aligned with the strategic focus of our company.

Our business development strategy is to form partnerships that create significant value for ourselves, our partners, and most importantly the patients who are at the center of everything we do.